Barclays Raises Price Targets On Healthcare Companies

Barclays analyst Joshua R. Raskin made Price Target changes to several healthcare companies Friday. Raskin noted that managed care as a group was up nearly 20 percent year-to-date versus the S&P 500‘s gain of 1.5 percent. The analyst have mentioned that "earnings momentum continues to build with EPS growth rates in 2015 reflecting stronger growth than recent years," and that "2016 earnings growth rates are above 2015 rates and indicative of the belief that managed care is exiting a more difficult period." Below are the price target changes along with current ratings for the healthcare stocks. Aetna Inc

- Overweight, Price Target raised from $119 to $122 Centene Corp

- Overweight, Price Target raised from $66 to $84 CIGNA Corporation

- Equal-weight, Price Target raised from $120 to $134 Health Net, Inc.

- Underweight, Price Target raised from $53 to $58 Humana Inc

- Equal-weight, Price Target raised from $155 to $190 Magellan Health Inc

- Equal-weight, Price Target raised from $68 to $73 UnitedHealth Group Inc.

- Overweight, Price Target raised from $124 to $138 WellCare Health Plans, Inc.

- Equal-weight, Price Target raised from $85 to $95